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Summary
Retinoids, in particular all-trans retinoic acid (T-RA), 
are essential for normal development and homeostasis 
of vertebrates. Although many effects of retinoids, par- 
ticularily with regard to teratogenicity, have been 
described in the literature, the mechanisms by which 
these simple signalling molecules work has only recently 
begun to be elucidated. We now recognize at least two 
classes of retinoid-binding proteins and two families of 
retinoid receptors. The ultimate interpretation of the 
retinoid signal within a given cell is probably the result 
of a complex series of interactions between these pro­
teins, yet little is understood concerning the role each
member of this signalling pathway plays. It is therefore 
imperative to dissect the molecular mechanisms which 
transduce the effects of these ligands, both in vivo and 
in isolated systems. One approach we are employing is 
gene targeting of retinoic acid receptors (RARs) and cel­
lular retinoid-binding proteins to generate mice in 
which one or more of these genes has been functionally 
inactivated.
Key words: retinoic acid receptors, retinoid X  receptors, cellular 
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Introduction
The term retinoid refers to any synthetic or natural com ­
pound which possesses vitamin A-like activity. At least 
three naturally occurring, biologically active, retinoids have 
been found which may regulate growth, differentiation and 
homeostasis o f the developing vertebrate: all-trans retinoic 
acid (T-RA), 9-cis retinoic acid (9C-RA; Levin et al., 1992; 
Heyman et al., 1992) and 3,4-didehydroretinoic acid (dd- 
RA; Thaller and Eichle, 1990). It has been proposed that 
retinoids may be natural morphogens (Maden, 1982, 1985; 
Tickle et al., 1982; Chytil, 1984; Slack, 1987; Thaller and 
Eichele, 1987; Smith et al., 1989; Eichele, 1989a,b; 
Brockes, 1989, 1990), although this viewpoint has been 
challenged recently by a number o f reports which question 
the validity of T-RA as a true morphogen (Brockes, 1991; 
Wanek et al., 1991; Noji et al., 1991). However, the effects 
o f ectopically administered T-RA, either during develop­
ment (and in the adult) o f several vertebrates or on cells in 
culture, have often been correlated with alterations in pat­
terns of expression and/or the level o f expression o f specific 
genes (eg. Wang and Gudas, 1983; LaRosa and Gudas, 
1988; Murphy et al., 1988; Chytil and Haq, 1990; Wang et 
al., 1990; Nicholson et al., 1990; Simeone et al., 1990; 
Kessel and Gruss, 1991; Izpisua-Belmonte et al., 1991). 
These observations strongly suggest that T-RA, in con­
junction with its receptor (discussed below), may directly 
regulate gene expression which would ultimately interpret
this putative morphogenetic signal. Alternatively, T-RA 
may act during development to regulate the expression of 
other factors which themselves may be true morphogens.
To date, two general classes o f retinoid-binding proteins 
have been implicated in the retinoid signalling pathway. 
First, the cellular retinoid-binding proteins which include 
cellular retinol-binding proteins (CRBPs) I and II (see 
Blom hoff et al., 1991, for review) and cellular retinoic acid- 
binding proteins (CRABPs) I and II (Blom hoff et al., 1990; 
Giguere et al., 1990a). These proteins bind their ligands 
(retinol and T-RA, respectively) with high affinity and 
specificity. The precise function of these proteins is 
presently unknown, but it has been speculated that they play 
a role in retinoid metabolism and in the regulation of free 
retinoid concentration (see below).
The second class of retinoid-binding proteins consists o f 
the products o f two multigene families: the retinoic acid 
receptors (RARa, (3 and y; for review, see Chambon et al.,
1991) and the retinoid X receptors (RXR a , (3 and y; Hamada 
et al., 1989; Mangelsdorf et al., 1990, 1992; Rowe et al., 
1991; Blumberg et al., 1992; Leid et al., 1992). Both classes 
of receptors are ligand-inducible, mms-regulators belonging 
to the nuclear receptor multigene family, which includes 
receptors for steroid hormones, thyroid hormones and vita­
min D 3 (Evans, 1988; Green and Chambon, 1988; Beato, 
1989; Moore, 1990). RARs can be efficiently activated by 
either T-RA or 9C-RA at 50 nM concentrations of either 
ligand. RXRs, on the other hand, are activated efficiently
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Fig. 1. Schem atic representation o f the com ponents o f  the 
retinoid-signalling pathway. CRBP, cellu lar retinol-binding 
protein; CRABP, cellular retinoic acid-binding protein; RBP, 
retinol-binding protein; RAR, retinoic acid receptor; RXR, 
retinoid X receptor.
only by 9C-RA in this concentration range. RXRs can, how­
ever, be activated by T-RA at high concentrations (1 |iM  or 
greater), probably through cellular conversion o f T-RA to 
the 9-cis isom er (Heyman et al., 1992; Levin et al., 1992). 
Thus, with respect to transactivation via RXRs, T-RA could 
be considered as a prohormone, possibly converted to the 
9-cis isomer, in either a localized or systemic fashion.
The major components o f the retinoid-signalling network 
discussed above are represented schematically in Fig. 1. To 
investigate how these proteins function ultimately to regu­
late diverse processes such as those involved in m orpho­
genesis and homeostasis in vertebrates will require efforts 
along many different experimental avenues. One approach 
consists o f disrupting the corresponding genes in the mouse 
via gene targeting (see Capecchi, 1989, for a review o f this 
technique). Our objective is to generate animal models in 
which the genes encoding a specific retinoid-binding pro­
tein or retinoid receptor (or a specific isoform o f a retinoid 
receptor - see below) has been functionally inactivated. 
These mouse models should provide useful tools for inves­
tigating the role that each of these proteins plays in trans­
duction of the retinoid signal. Before describing the details 
of our gene targeting experiments, a review of retinoid-bind­
ing proteins and retinoid receptors will first be presented.
Cellular retinoid-binding proteins
The two classes o f cellular retinoid-binding proteins
(CRBPI and II; CRABPI and II), while not directly im pli­
cated in transduction of the retinoid signal, probably play 
important roles in the ultimate response o f a given cell type 
to retinoids.
CRBPs may play a role in the storage and metabolism 
of retinol, itself a precursor to T-RA (Blom hoff et al.,
1990). CRBPI has been suggested to regulate the formation 
o f the major storage form of retinol, retinly esters (Ong et 
al., 1987), whereas CRBPII may mediate intracellular trans­
port o f retinol during the adsorption of this com pound from 
the intestinal lumen (Ong, 1987; Ong et al., 1987). In 
addition, transcripts encoding CRBPI are T-RA-inducible 
(Levin et al., 1987; Smith et al., 1991), which may repre­
sent an in vivo feedback mechanism which ultimately reg­
ulates the am ount of retinol available for conversion to T ­
RA. The restricted spatio-tem poral expression pattern of 
these two genes during mouse developm ent and in the adult 
also suggests tissue-specific functions (Dolle et al., 1989; 
Ruberte et al., 1991).
CRABPI and II bind T-RA with high, although slightly 
different, affinities (Blom hoff et al., 1990, 1991; Giguere 
et al., 1990a; S toner and Gudas, 1989). Again, the precise 
function that these two proteins fulfil is, at present, 
unknown. It has been speculated that they may be neces­
sary for transport o f T-RA to the nucleus, where it may be 
transferred to one o f the RARs (Takase et al., 1979, 1986). 
Alternatively, CRABPs have been suggested to control the 
actual intracellular concentration of free RA within a given 
cell (Maden et al., 1988; Smith et al., 1989; Ruberte et al.,
1991). CRABPII, like CRBPI, is inducible by retinoic acid 
(Wei et al., 1989; Giguere et al., 1990a; Durand et al.,
1992), perhaps providing a feedback mechanism  whereby 
excess ligand could be sequestered, thus preventing inap­
propriate expression of RA-responsive genes. It is clear that 
the presence o f these proteins is not obligatory for a cellu­
lar response to T-RA, as numerous retinoid-responsive cell 
lines have been docum ented which contain no detectible 
CRABPs.
Retinoic acid receptors and retinoid X receptors
Three hom ologous RARs have been discovered in our lab­
oratory and in others: R A R a (Petkovich et al., 1987; 
Giguère et al., 1987), RAR(3 (de Thé et al., 1987; Brand 
et al., 1988; Benbrook et al., 1988) and RARy (Zelent et 
al., 1989; Krust et al.. 1989; Ishikawa et al., 1990). These 
genes map to different chrom osom es in both m ouse (chro­
m osom e 11, 14 and 15 for a ,  P and y respectively) and 
human (chrom osom e 17, 3 and 12 respectively; M attei et 
al., 1991). Hom ologues for all three receptors have also 
been found in am phibians (Ragsdale et al., 1989; Giguère 
et al., 1989; Ragsdale and Brockes, 1991) and in chicken 
(Smith and Eichele, 1991), suggesting that these three 
genes have been conserved throughout the evolution of 
higher vertebrates.
M ore recent w ork has shown that the RXR family, com ­
posed of three subtypes (a , (3 and y), is also conserved 
across species (Leid et al., 1992; M angelsdorf et al., 1992 
and references therein). It is interesting to note that a 
Drosophila hom ologue, ultraspiracle, has been docum ented
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for RXRs (Oro et al., 1990), indicating that this gene family 
may be more ancestral than the RARs.
Although the discovery of the RXR family with a'unique 
and specific ligand (see above) suggested initially a diver­
gent retinoid-signalling pathway, recent results indicate that 
the RAR and RXR families may, in fact, represent con­
vergent signalling pathways. This observation comes from 
several groups which have shown that, at least in vitro, 
RAR/RXR heterodim ers form both in solution and on cer­
tain RAREs (retinoic acid response elements), and that this 
com plex transactivates T-RA responsive promoters much 
more efficiently than hom odim ers of either receptor (Yu et 
al., 1991; Kliewer et al., 1992; Leid et al., 1992; Zhang et 
al.. 1992; Durand et al., 1992). Thus, if one argues that 
these heterodim ers function in an analogous manner in vivo, 
the pleiotropic effects o f retinoids may be explained, at least 
in part, by the m ultitude of combinatorial possibilities 
between these two receptor types and the availability of 
each specific ligand.
Sequence com parison of the retinoic acid 
receptors
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Fig. 2. Com parison o f am ino acid sequence hom ology betw een 
hum an and m ouse RAR subtypes. The am ino acid residue num ber 
corresponding to the boundary o f each region is given at the top, 
and percent sequence hom ology com parison between hum an and 
m ouse receptors given at the bottom.
RARs, like all members o f the nuclear receptor superfam ­
ily, have a m odular structure consisting of six regions des­
ignated A-F (Green and Chambon, 1988). Previous reseach 
has shown that region C represents the DNA-binding 
domain, via folding into a zinc-stabilized structure. This 
domain also represents the most highly conserved region of 
this receptor family (Evans, 1988; Green and Chambon,
1988). The E region represents the ligand-binding domain 
whereas both the A/B and E regions o f several steroid hor­
mone receptors have been shown to harbour distinct trans­
activation dom ains which may operate in both a cell type 
and promoter-specific manner (W ebster et al., 1988; Boc- 
quel et al., 1989; Tora et al., 1989).
W hen RARs are com pared across species, the amino acid 
sequences are highly conserved (eg. m ouse and human; 
Krust et al., 1989; Zelent et al., 1989; Fig. 2). However, 
com parison of the three receptor subtypes within a given 
species reveals that only regions B, C and E are highly con­
served. This observation implies that each RAR may be 
functionally distinct, possibly regulating a subset of 
retinoid-responsive genes in a cell-type and/or promotor- 
dependent fashion. This is further substantiated by the find­
ing of separate spatio-tem poral expression patterns for the 
RARs during em byronic developm ent (see below).
Retinoic acid receptor isoforms
The discovery o f isoforms for all mouse RAR (mRAR) 
types adds an additional level o f com plexity to RAR 
expression. To date two main isoforms have been discov­
ered for m R A R a (Leroy et al., 1991a), four for mRAR(3 
(Zelent et al., 1991; Nagpal et al., 1992a) and two for 
mRARy (Kastner et al., 1990; Giguere et al., 1990b; Fig. 
3). The structure o f  these isoforms shares a common motif; 
for any RAR type, each isoform  diverges only in the 5 '- 
untranslated and A region. The sequence from the B region
to the S '-untranslated sequence remains identical. In the 
mouse these isoform s are expressed under the control o f at 
least two independent promoters, and result from  differen­
tial splicing (Kastner el al., 1990; Brand et al., 1990; Leroy 
et al., 1991a; Zelent et al., 1991; see Fig. 3). It is interest­
ing to note that the isoforms m R A R a2 and all mRAR(3 tran­
scripts are induced by T-RA, suggesting yet another level 
o f com plexity in this gene network. Two of these genes, 
m R A R a2 and mRAR(32, contain a sim ilar RARE in their 
prom oter regions which likely mediates the T-RA-induced 
expression of these genes (de Thé et al., 1990; Sucov et al., 
1990; Leroy et al., 1991b). Recently, a divergent RARE has 
been described for RARy2 (Lehmann et al., 1992). The sig­
nificance o f the m inor isoforms a 3  to a l  and y3 to y6 is 
unclear (Kastner et al., 1990; Leroy et al., 1991a; Zelent et 
al., 1991).
As for RAR types, sequence com parisons of mouse and 
human RAR isoforms again reveals a striking level of 
homology across species (Kastner et al., 1990; Leroy et al., 
1991a; Zelent et al., 1991). This sequence conservation is 
exhibited not only in the A region, but also extends to the 
5'-untranslated region of each isoform, suggesting the reten­
tion of conserved mechanisms that may involve regulation 
of translation, mRNA stabilization or other events impor­
tant for proper expression of these proteins.
As discussed above, transcription activating functions 
(AFs) have been ascribed previously to the A/B and E 
regions of other members o f the steroid hormone super­
family, such as the estrogen receptor. Thus, each mRAR 
isoform could differ in its transactivation capabilities at a 
given prom oter via the difference in its A region. Indeed, 
recent work from our laboratory shows that the different 
RAR subtypes do indeed possess AFs in the E region, as 
well as different transcription modulation activities in the 
A/B region that function in a prom oter-dependent manner 
(Nagpal et al., 1992b).
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Fig. 3. Schem atic representation o f the 5' region o f  the three 
m ouse RA R  genes and o f  their m ajor isoform s. The exons (E) are 
indicated by boxes and are num bered as in Kastner et al. (1990), 
Leroy et al. (1991a) and Z elent et al. (1991). W hite boxes 
represent 5 '-untranslated  sequences and black boxes represent 
translated sequences. For a given RAR isoform , the num bering 
A 1, A2, A3 and B represents the A l , A2, A3 and B regions o f the 
receptor isoform s. For each receptor, PI and P2 correspond to the 
upstream  and dow nstream  prom oters, respectively.
Mouse retinoic acid receptors and isoforms are 
differentially expressed during developm ent
Initial northern blot analysis (Petkovich et al., 1987; Krust 
et al., 1989; Zelent et al., 1989) and in situ analysis (Dolle 
et al., 1989, 1990; Ruberte et al., 1990, 1991) revealed a 
wide and differential pattern of expression for all three 
RARs in both the developing and adult mouse. Further 
northern blot analysis using probes specific for the major 
mRAR isoforms has shown additional evidence for iso­
form-specific expression. In summary, m R A R al 
expression has been found to be ubiquitous, which is in 
keeping with the structure of the prom oter for this gene 
(Brand et al., 1990; Leroy et al., 1991a). The presence of 
this transcript in essentially all cell types may reflect a gen­
eral requirem ent for retinoid-dependent gene regulation. In 
contrast, m R A R a2 has a more restricted pattern of 
expression, and this transcript is RA-inducible in em bry­
onal carcinom a (EC) cell lines such as P19 and F9, con­
sistent with the presence of a RARE in the promoter o f this 
gene (Leroy et al., 1991b).
m R A R pi and P3 transcripts are abundant in adult and 
em bryonic brain, which may indicate a requirem ent for
these isoforms in the developm ent of the central nervous 
system (Zelent et al., 1991). As mentioned above, all three 
mRARP isoforms are RA-inducible in EC cells which is 
consistent with the presence of a functional RARE in the 
RARp2 prom otor (de Thé et al., 1990; M endelsohn et al.,
1991). A sim ilar m otif has not yet been identified in the 
prom oter for the m R A R pi or P3 genes.
m RARyl is expressed mainly in adult skin, whereas 
mRARy2 transcripts are more abundant in early em bryo­
genesis and in EC cells (Kastner et al., 1990). Previous in 
situ analysis indicates that RARy may also play a role in 
chondrogenesis, as this gene is highly expressed in con­
densing precartilage during mouse em bryogenesis (Dollé et 
al., 1989, 1990).
Summ ary of the system
As discussed above, the response o f a given cell to retinoids 
will depend on a com plex series of parameters, only some 
o f which have been discussed here. It is clear that at least 
three endogenous retinoids may activate gene transcription 
(T-RA, 9C-RA and ddRA). The synthesis and distribution 
o f these m etabolites has not been fully elucidated, although 
this will surely be o f great importance with regard to 
retinoid-dependent developmental processes. Cellular 
retinoid-binding proteins (CRBP1 and II; CRABPI and II) 
are likely to play a pivotal role in regulating cellular 
responses to retinoids, possibly by controlling both the for­
mation and concentration o f free ligand capable of binding 
to nuclear receptors. Finally, at least eight m ajor species of 
RARs (3 subtypes; 8 isoforms) and three species of RXRs 
(which may also be expressed as isoforms: Fleischhauer et 
al., 1992; Leid et al., 1992) have been documented. If one 
considers the possibility that these receptors may function 
in vivo as RAR:RXR heterodimers, through activation by 
two different ligands and possibly in a prom oter and cell- 
type specific fashion, it is clear that the com binatorial pos­
sibilities becom e considerable. This diversity through 
varied com binations may begin to explain the pleiotropic 
effects o f retinoids in vivo. On the other hand, one may 
argue that this diversity may represent functional redun­
dancy, a hypothesis currently impossible to refute with any 
direct evidence.
Gene targeting of com ponents of the RA-signal 
transduction network
In order to determ ine which role(s) each of the above pro­
teins may possibly play in development and homeostasis, 
we have begun gene targeting experiments, w ith the ulti­
mate goal o f  establishing m ouse lines in which each mRAR 
(or major m RAR isoform) or cellular retinoid-binding pro­
tein has been disrupted. This is being accom plished via 
homologous recombination in embryonic stem (ES) cells, 
as reviewed by Capecchi (1989). The results obtained from 
these experim ents should provide valuable insight as to the 
specific roles these genes play during m urine developm ent 
and homeostasis o f the m ature animal.
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Gene targeting of retinoid receptors and retinoid- 
binding proteins
The methodology, cell lines and mouse strains used in our 
gene targeting experim ents have been described in detail 
previously (Lufkin et al., 1991). Briefly, we use the ES cell 
line D3 (a kind gift from R. Kemler, Frieberg, Germany), 
cultured under standard conditions. Targeting constructs are 
generally of the replacem ent type (Capecchi, 1989), in 
which a neom ycin resistance (neo) gene casette has been 
inserted into exonic sequences of an engineered genom ic 
fragment. The purpose of the neo gene is twofold; firstly, 
it allows selection of integration events via cellular resis­
tance to G418; secondly, it is used to disrupt the coding 
region o f the targeted gene upon hom ologous recom bina­
tion with the cognate ES cell allele. These constructs are 
linearised outside the region of homology to the target allele 
and used to electroporate D3 ES cells (usually 107 cells/ 
electroporation). Selection for the expression of the neo 
gene is perform ed using 150 |ig/m l G418 for 12 days. In 
some experiments, negative selection against the expression 
of a HSV Tk gene (positive/negative selection; Capecchi,
1989) with 2 |iM  gancyclovyr is also used. Surviving 
colonies are isolated, propagated and used for either PCR 
or genom ic Southern blotting analysis to identify clones in 
which hom ologous recom bination has occured. Cells from 
positive clones (10-20 cells) are then injected into 3.5-day 
m ouse em bryos (blastocysts) and the resulting em bryos are 
reimplanted into pseudo-pregnant recipient females. Result­
ing male chimeras are then outbred with C57B1/6 females. 
Germ line transm ission (passage o f the injected ES cell 
genotype to the Fi progeny) can be observed initially via 
the coat colour o f the offspring. Pups carrying the m uta­
tion are identified by Southern blot analysis. Heterozygote 
animals are analyzed for phenotypic alterations and if  viable 
and fertile are then inbred to obtain homozygote mutants 
for subsequent phenotypic analysis.
Gene targeting o f the m R A R al locus will be used as a
paradigm  for disruption of other mRARs and retinoid-bind­
ing proteins. This isoform is the most ubiquitously 
expressed mRAR (as discussed above). As described pre­
viously, mRAR isoforms differ only in their 5'-untranslated 
and A regions. The strategy for disrupting a specific iso­
form, therefore, is to design a construct by which, after 
homologous recom bination, the isoform will undergo pre­
mature term ination in the A domain specific for that par­
ticular mRAR.
For the m R A R a locus, a num ber of genom ic clones have 
been described previously (Leroy et al., 1991a). For homol­
ogous recom bination, a suitable subclone was obtained 
which contained exon 2 of the m R A R a transcription unit. 
This exon is specific for m R A R al, and contains a portion 
o f its 5 '-untranslated region and the entire A region of this 
gene. Using this genom ic fragment, a construct was pre­
pared in which a neo cassette was inserted into the open 
reading frame o f this exon (see Fig. 4). Homologous recom ­
bination o f this construct with the cognate ES cell allele 
should result in a null mutation for this isoform via pre­
mature term ination of the gene product at stop codons 
located in the 5 ' end of the neo casette (Fig. 4). In order to 
avoid possible alteration of expression levels of the 
m R A R a2 gene, which lies downstream of this locus, the 
neo casette used was driven by a minimal promoter, which 
consists only of the Rous sarcoma virus TATA box and 
lacks any viral enhancer sequences (derived from the neo 
casette p566 used by Lufkin et al., 1991). As depicted in 
Fig. 4, the close proximity o f the 3 ' end o f the neo casette 
with respect to the 3 ' boundary of the homologous recom ­
bination event should allow positive clones to be detected 
by a PCR reaction via amplification of a 1 kb product 
specific for the targeted allele.
As expected for a minimal promoter, a low num ber (22) 
o f G418 resistant colonies were obtained using this target­
ing construct. PCR analysis o f genomic DNA obtained from 
these clones, however, revealed three positive cell lines 
(Fig. 5). Thus, at least at this allele, a strong enhancer/pro-
TARGETING CONSTRUCT
TGA internal PCR primer
T a ta -N e o  B ----------
WILD TYPE ALLELE 
------- 1--------------
Exon 1; RARal 
51-ÜTR
HOMOLOGOUS RECOMBINANT
Exon 2; RARal 
5 '-UTR and A Domain
external PCR 
primer
- ^ B ~ T a t a -N e o
Exon 1; RARal 
5'-ÜTR PCR PRODUCT
1 Kb
Fig. 4. H om ologous 
recom bination strategy for 
R A R a  1. The targeting 
construct, target allele and 
predicted hom ologous 
recom binant are indicated. 
Exons are denoted as black 
boxes. The TG A  w ithin the 
Tata-neo cassette represents 5 ' 
stop sites present upstream  o f 
the neo coding region. The 
AU G  in exon two o f  the 
R A R a l transcription unit 
represents the initiation codon 
for the R A R a l protein. The 
location o f PCR prim ers are 
noted by horizontal arrows, and 
the predicted PCR reaction 
product by a thick horizontal 
line.
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Fig. 5. PCR analysis for hom ologous recom bination at the 
R A R a l allele. G enom ic DN A  was isolated from  ES cell colonies 
electroporated w ith the construct shown in Fig. 4. The per was 
carried out under standard conditions using primers as indicated in 
Fig. 4. A sam ple o f  each reaction was run on an agarose gel and 
stained with ethidium  brom ide. Tw o positive cell lines (KA3 and 
KA5) are shown in the figure. A third positive line (KA 26) is not 
indicated.
moter driving the expression of the neo gene is not neces­
sary to obtain targeting events. These clones were expanded 
and injected into blastocysts to generate chimeras. All three 
clones gave chimeric males which passed the mutated allele 
to their offspring (Table 1). W e have since inbred het-
T ab le  1. Germ line transmission o f the R A R al null 
mutation
Number of Genotype
Chimera Clone Offspring Agouti (+/-:
1 KA3 0 0
2 KA3 20 18 7
3 KA3 0 0
4 KA3 19 9 3
5 KA3 4 4 1
6 KA3 36 25 18
7 KA5 16 16 11
8 KA5 19 10 7
9 KA5 0 0
10 KA5 0 0
11 KA5 31 17 6
12 KA26 13 4 1
13 KA26 17 16 6
14 KA26 55 45 31
15 KA26 20 20 8
16 KA26 37 32 14
17 KA26 10 10 4
18 KA26 4 0
19 KA26 3 3 1
20 KA26 9 0
21 KA26 18 16 7
22 K.A26 0 0
The positive ES clones identified by the per in Fig. 5 were injected into 
blastocysts and the resulting male chimeras bred with C 57B 1/6 females. 
Germ line transmission was initially scored by the presence o f agouti coat 
colour. Pups carrying the mutated allele were identified by genomic 
Southern blot analysis o f tail tip DNA. (+ /-) indicates the number of 
heterozygote animals present among the agouti offspring.
erozygote animals to generate homozygote mutant off­
spring, and are currently exam ining these animals for any 
phenotypic changes resulting from  the loss o f this gene 
product. It is important to note that recombination of this 
construct at the m R A R al locus has no measurable effect 
on the expression of the m R A R a2 gene (data not shown). 
The strategy o f using a minimal promoter to express the 
neo gene may therefore be of general use for targeted dis­
ruption of genes which lie in proximity to other transcrip­
tion units.
In analogous experiments, we have successfully targeted 
a num ber o f mRARs and mRAR isoforms including 
m R A R al, m R A R a (all isoforms), mRAR(32, mRARfS (all 
isoforms), mRARy2, m R A R y(all isoforms). In addition, we 
have successfully disrupted the genes encoding mouse cel­
lular retinoid-binding proteins CRABPI and II.
Conclusions
The ultim ate interpretation of retinoid signalling at a cel­
lular level is influenced by a large num ber of interactive 
gene products, including: (1) cellular retinoid-binding pro­
teins, which may regulate the formation of active retinoids 
or control the cellular concentration of free ligand available 
to associate with retinoid receptors; (2) retinoid receptors 
which include at least two families, the three RARs and the 
three RXRs. These receptor families are com posed o f at 
least 11 different members (including isoforms), and are 
under a strict developmental expression program , as evi­
denced by their different spatio-tem poral expression pat­
terns in the developing mouse. An additional level o f com ­
plexity with regard to control o f retinoid-responsive target 
gene expression may be brought about through het- 
erodim erization of RARs and RXRs to activate differen­
tially, possibly in a cell-type and promoter-specific manner, 
subsets o f these target genes. An additional consideration, 
not discussed here, is the regulation of retinoid biosynthe­
sis. The enzymes controlling the production, and possibly 
the catabolism, o f the various biologically active retinoids 
(eg. T-RA, 9C-RA and ddRA) may also play a pivotal role 
in this network.
In order to further investigate the role(s) that each of 
these genes play in m urine development, we have sucess- 
fully used gene targeting via homologous recom bination in 
ES cells to create null mutants for a num ber o f the key 
players in the retinoid signalling pathway. Subsequent 
analysis of the phenotypic changes brought about by these 
null mutations should give valuable insight as to the 
processes that are regulated by each of these proteins, and 
thus further our understanding of the function(s) performed 
by each m em ber of this signalling pathway.
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